Medicine & Life Sciences
Ovarian Neoplasms
100%
Poly(ADP-ribose) Polymerase Inhibitors
72%
Neoplasms
56%
Breast Neoplasms
49%
Up-Regulation
41%
Diapause
41%
Y-Box-Binding Protein 1
40%
Ferroptosis
38%
Mitogen-Activated Protein Kinase Kinases
37%
Amphiregulin
36%
Isogeneic Transplantation
36%
DNA Damage
36%
Adenosine Diphosphate Ribose
35%
Single-Cell Analysis
32%
Cyclin E
31%
Phosphatidylinositol 3-Kinases
30%
erastin
29%
Cyclins
29%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
28%
Deoxyglucose
28%
Heterografts
27%
Homologous Recombination
27%
MicroRNAs
27%
AICA ribonucleotide
26%
Growth
26%
Precision Medicine
26%
Metformin
26%
Endometrial Neoplasms
25%
Phosphorylation
23%
Therapeutics
23%
Phosphatidylinositol 3-Kinase
22%
Mutation
20%
Cell Line
20%
Intercellular Signaling Peptides and Proteins
19%
Cell Death
19%
ErbB Receptors
18%
Cell Proliferation
17%
AMP-Activated Protein Kinases
16%
Neoplasm Metastasis
15%
Lysophosphatidic Acid Receptors
14%
Transcriptional Activation
14%
Pharmaceutical Preparations
13%
MAP Kinase Signaling System
13%
In Vitro Techniques
12%
Transplants
12%
Adenosine
11%
Clinical Trials
11%
Autophagy
11%